BERARDICURTI, ONORINA
 Distribuzione geografica
Continente #
NA - Nord America 275
EU - Europa 160
AS - Asia 43
SA - Sud America 6
AF - Africa 2
OC - Oceania 2
Totale 488
Nazione #
US - Stati Uniti d'America 263
GB - Regno Unito 84
IT - Italia 46
IN - India 19
CA - Canada 12
DE - Germania 9
FR - Francia 8
JP - Giappone 7
SG - Singapore 5
AR - Argentina 4
ES - Italia 4
IL - Israele 3
AU - Australia 2
BG - Bulgaria 2
MA - Marocco 2
PK - Pakistan 2
PL - Polonia 2
SA - Arabia Saudita 2
TR - Turchia 2
CH - Svizzera 1
CL - Cile 1
CO - Colombia 1
HK - Hong Kong 1
KZ - Kazakistan 1
LV - Lettonia 1
MD - Moldavia 1
RS - Serbia 1
RU - Federazione Russa 1
TH - Thailandia 1
Totale 488
Città #
Ashburn 125
London 79
Council Bluffs 41
Boardman 21
Pune 14
San Francisco 14
Washington 13
Rome 12
Bari 11
Toronto 11
Seattle 8
West Jordan 8
Noicattaro 4
Singapore 4
State College 4
Tokyo 4
Tel Aviv 3
Anantapur 2
Brest 2
Collazzone 2
Florencio Varela 2
Herne Bay 2
L'aquila 2
Makkah 2
Naples 2
Reus 2
Secaucus 2
Sofia 2
Takatsuki Shi 2
Warsaw 2
Aioicho 1
Bangkok 1
Belgrade 1
Boydton 1
Buenos Aires 1
Buffalo 1
Central 1
Charlotte 1
Chennai 1
Chicago 1
Chisinau 1
Danvers 1
Hanover 1
Hyderabad 1
Islamabad 1
Karachi 1
Lecce 1
Los Angeles 1
Markham 1
Melbourne 1
Newark 1
Pamplona 1
Paris 1
Pontonx-sur-l'Adour 1
Rabat 1
Redmond 1
Riga 1
Santiago de Cali 1
Siena 1
Sydney 1
Tangier 1
Totale 433
Nome #
SARS-CoV-2 infection in patients with primary Sjögren syndrome: characterization and outcomes of 51 patients 40
2-Arachidonoylglycerol Reduces the Production of Interferon-Gamma in T Lymphocytes from Patients with Systemic Lupus Erythematosus 29
Benefits of anakinra versus TNF inhibitors in rheumatoid arthritis and type 2 diabetes: long-term findings from participants furtherly followed-up in the TRACK study, a multicentre, open-label, randomised, controlled trial 13
Duration of clinical remission and low disease activity impacts on quality of life and its domains in psoriatic arthritis patients: results from an Italian multicentre study 13
Laboratory assessment in patients with suspected rheumatic musculoskeletal diseases: challenges, pitfalls and perspectives 11
Association Between Minor Salivary Gland Biopsy During Sjӧgren's Syndrome and Serologic Biomarkers: A Systematic Review and Meta-Analysis 10
Tofacitinib May Inhibit Myofibroblast Differentiation from Rheumatoid-Fibroblast-like Synoviocytes Induced by TGF-β and IL-6 9
Mesenchymal stem cells of Systemic Sclerosis patients, derived from different sources, show a profibrotic microRNA profiling 9
Disparities in the prevalence of clinical features between systemic juvenile idiopathic arthritis and adult-onset Still's disease 9
Long-term Safety of Rituximab in Primary Sjögren Syndrome: The Experience of a Single Center 9
Beyond the joints, the extra-articular manifestations in rheumatoid arthritis 9
Dissecting the clinical heterogeneity of adult-onset Still's disease: results from a multi-dimensional characterization and stratification 9
The negative impact of pain catastrophising on disease activity: analyses of data derived from patient-reported outcomes in psoriatic arthritis and axial spondyloarthritis 8
Correction to: Impact of smoking habit on adult-onset Still's disease prognosis, findings from a multicentre observational study 8
H-ferritin and proinflammatory cytokines are increased in the bone marrow of patients affected by macrophage activation syndrome 8
Biologic therapies and infections in the daily practice of three Italian rheumatologic units: a prospective, observational study 8
H-ferritin and CD68(+) /H-ferritin(+) monocytes/macrophages are increased in the skin of adult-onset Still's disease patients and correlate with the multi-visceral involvement of the disease 8
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management. 8
Blocking Jak/STAT signalling using tofacitinib inhibits angiogenesis in experimental arthritis 8
The clinical heterogeneity of adult onset Still's disease may underlie different pathogenic mechanisms. Implications for a personalised therapeutic management of these patients 7
Incidence of venous thromboembolism in rheumatoid arthritis, results from a "real-life" cohort and an appraisal of available literature 7
Possible role for IL-40 and IL-40-producing cells in the lymphocytic infiltrated salivary glands of patients with primary Sjögren's syndrome 7
Persistence of C-reactive protein increased levels and high disease activity are predictors of cardiovascular disease in patients with axial spondyloarthritis 7
The similar expression of both ferritin and scavenger receptors activation genes in patients with COVID19 and AOSD support their role in the pathogenesis of these diseases and identify a common mechanism at the basis of the "hyperferritinemic syndromes" 7
Severe COVID-19 and related hyperferritinaemia: more than an innocent bystander? 7
Is minor salivary gland biopsy more than a diagnostic tool in primary Sjo¨gren׳s syndrome? Association between clinical, histopathological, and molecular features: A retrospective study 7
Cardiovascular disease in primary sjögren’s syndrome 7
Interstitial lung disease in systemic sclerosis: current and future treatment. 7
The joint involvement in adult onset Still's disease is characterised by a peculiar magnetic resonance imaging and a specific transcriptomic profile 7
Mortality in tocilizumab-treated patients with COVID-19: a systematic review and meta-analysis 6
Cytokine profile, ferritin, and multi-visceral involvement characterise macrophage activation syndrome during adult-onset Still's disease 6
Interstitial Lung Disease and Pulmonary Damage in Primary Sjögren's Syndrome: A Systematic Review and Meta-Analysis 6
Response to: 'Correspondence on 'Lung involvement in macrophage activation syndrome and severe COVID-19: results from a cross-sectional study to assess clinical, laboratory and artificial intelligence-radiological differences' by Ruscitti et al' by Chen et al 6
Adipocytokines in Rheumatoid Arthritis: The Hidden Link between Inflammation and Cardiometabolic Comorbidities 6
Searching for a good model for systemic sclerosis: The molecular profile and vascular changes occurring in UCD-200 chickens strongly resemble the early phase of human systemic sclerosis 6
Parenchymal lung disease in adult onset Still's disease: An emergent marker of disease severity - Characterisation and predictive factors from Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort of patients 6
Blocking CD248 molecules in perivascular stromal cells of patients with systemic sclerosis strongly inhibits their differentiation toward myofibroblasts and proliferation: A new potential target for antifibrotic therapy 6
Advances in immunopathogenesis of macrophage activation syndrome during rheumatic inflammatory diseases: toward new therapeutic targets? 6
Impact of smoking habit on adult-onset Still's disease prognosis, findings from a multicentre observational study 6
The hyper-expression of NLRP4 characterizes the occurrence of macrophage activation syndrome assessing STING pathway in adult-onset Still's disease 5
Rheumatic manifestations of COVID-19: a systematic review and meta-analysis 5
The CD68+/H-ferritin+ cells colonize the lymph nodes of the patients with adult onset Still's disease and are associated with increased extracellular level of H-ferritin in the same tissue: Correlation with disease severity and implication for pathogenesis 5
Perivascular cells in diffuse cutaneous systemic sclerosis overexpress activated ADAM12 and are involved in myofibroblast transdifferentiation and development of fibrosis 5
Role of CD248 molecule as potential regulator of trans-differentiation toward myofibroblasts of perivascular stromal cells in systemic sclerosis patients 5
ASSESSING PRO-INFLAMMATORY PROPERTIES OF H-FERRITIN BY EX VIVO AND IN VITRO OBSERVATIONS 5
Adult-onset Still's disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers 5
Managing Adult-onset Still's disease: The effectiveness of high-dosage of corticosteroids as first-line treatment in inducing the clinical remission. Results from an observational study 5
Pro-inflammatory properties of H-ferritin on human macrophages, ex vivo and in vitro observations 5
Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study 5
Macrophage activation syndrome in Still's disease: analysis of clinical characteristics and survival in paediatric and adult patients. 5
The growing role of precision medicine for the treatment of autoimmune diseases; results of a systematic review of literature and Experts' Consensus 5
Unenhanced Cardiac Magnetic Resonance may improve detection and prognostication of an occult heart involvement in asymptomatic patients with systemic sclerosis 5
Maladaptive Autophagy in the Pathogenesis of Autoimmune Epithelitis in Sjögren's Syndrome 5
Cytokine storm syndrome in severe COVID-19 5
The emerging role of IL-1 inhibition in patients affected by rheumatoid arthritis and diabetes 4
Glucocorticoids in Rheumatoid Arthritis: The Silent Companion in the Therapeutic Strategy 4
Vitamin D and systemic lupus erythematosus - The hype and the hope 4
Macitentan inhibits the transforming growth factor-β profibrotic action, blocking the signaling mediated by the ETR/TβRI complex in systemic sclerosis dermal fibroblasts 4
Clinical features and prognosis of COVID-19 in people with spinal cord injury: a case–control study 4
Impaired Endothelium-Mesenchymal Stem Cells Cross-talk in Systemic Sclerosis: a Link Between Vascular and Fibrotic Features 4
IL-1 inhibition improves insulin resistance and adipokines in rheumatoid arthritis patients with comorbid type 2 diabetes: An observational study 4
Association between clinical, histopathological and molecular features in primary Sjogren's Syndrome: a retrospective study 4
Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis 4
IL-1β at the crossroad between rheumatoid arthritis and type 2 diabetes: may we kill two birds with one stone? 4
Endothelial-to-mesenchymal transition in systemic sclerosis 4
Poor clinical response in rheumatoid arthritis is the main risk factor for diabetes development in the short-term: A 1-year, single-centre, longitudinal study. 3
Severe COVID-19, Another Piece in the Puzzle of the Hyperferritinemic Syndrome. An Immunomodulatory Perspective to Alleviate the Storm. 3
Increased level of H-ferritin and its imbalance with L-ferritin, in bone marrow and liver of patients with adult onset Still's disease, developing macrophage activation syndrome, correlate with the severity of the disease. 3
SAT0489 Biologic Therapies and Infections in The Daily Practice: A Study on Historical Cohort from 3 Italian Rheumatologic Units 3
THU0582 Prognostic Factors of Macrophage Activation Syndrome in Adults: Analysis of 40 Cases in 2 Tertiary Referral Centers 3
Italian recommendations for influenza and pneumococcal vaccination in adult patients with autoimmune rheumatic diseases 3
The incidence of cardiovascular events in Italian patients with systemic lupus erythematosus is lower than in North European and American cohorts: Implication of disease-associated and traditional risk factors as emerged by a 16-year retrospective GIRRCS study 3
Lung involvement in macrophage activation syndrome and severe COVID-19: results from a cross-sectional study to assess clinical, laboratory and artificial intelligence-radiological differences 3
Interleukin-32 in systemic sclerosis, a potential new biomarker for pulmonary arterial hypertension 3
Myofibroblast Cells Expression of CD248 May Contribute to Exacerbate Microvascular Damage during Systemic Sclerosis 3
Peripheral Nervous System Involvement in Sjögren's Syndrome: Analysis of a Cohort From the Italian Research Group on Sjögren's Syndrome 3
Immunofibroblasts regulate LTα3 expression in tertiary lymphoid structures in a pathway dependent on ICOS/ICOSL interaction 3
Pharmacological stress, rest perfusion and delayed enhancement cardiac magnetic resonance identifies a very early cardiac involvement in systemic sclerosis patients of recent onset 2
Mesenchymal stromal cells and rheumatic diseases: new tools from pathogenesis to regenerative therapies. 2
Epidermal Growth Factor Like-domain 7 and miR-126 are abnormally expressed in diffuse Systemic Sclerosis fibroblasts 2
Prognostic factors of macrophage activation syndrome, at the time of diagnosis, in adult patients affected by autoimmune disease: Analysis of 41 cases collected in 2 rheumatologic centers 1
FRI0613 H-ferritin and pro-inflammatory cytokines are increased in the bone marrow of adult patients affected by macrophage activation syndrome 1
The Role of IL-1β in the Bone Loss during Rheumatic Diseases 1
Increased cardiovascular events and subclinical atherosclerosis in rheumatoid arthritis patients: 1 year prospective single centre study 1
The Endothelial-mesenchymal Transition in Systemic Sclerosis Is Induced by Endothelin-1 and Transforming Growth Factor-β and May Be Blocked by Macitentan, a Dual Endothelin-1 Receptor Antagonist. 1
The specialized pro-resolving lipid mediator Protectin D1 affects macrophages differentiation and activity in Adult-onset Still's disease and COVID-19, two hyperinflammatory diseases sharing similar transcriptomic profiles 1
Totale 523
Categoria #
all - tutte 13.918
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.918


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022111 0 0 2 0 0 0 0 0 18 4 5 82
2022/202398 1 2 2 4 15 1 2 8 3 5 54 1
2023/2024314 16 35 15 40 40 139 7 10 3 9 0 0
Totale 523